Agreement with BioView to develop a CTC-based HER2 assay First phase expected to generate c. £1.2 million revenue GUILDFORD, UK / ACCESSWIRE / April 19, 2023 / ANGLE plc (AIM:AGL), (OTCQX:ANPCY), a ...
ANGLE AND BIOVIEW TO PRESENT COMBINED SOLUTION FOR CIRCULATING TUMOR CELL DETECTION AND ANALYSIS AT MOLECULAR MED TRI-CON 2020 IN SAN FRANCISCO, 4 MARCH 2020 GUILDFORD, SURREY / ACCESSWIRE / February ...
BioView and ScreenCell inked a commercial collaboration that will apply BioView’s Automated Cell Imaging Systems to image circulating tumor cells (CTCs) isolated using ScreenCell’s CytoKit® platform.
ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is delighted to announce it has signed an agreement with BioView Ltd. ("BioView") (BIOV.TA) to develop a liquid biopsy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results